rs763621894
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007218.4(RNF139):c.571G>A(p.Val191Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007218.4 missense
Scores
Clinical Significance
Conservation
Publications
- nonpapillary renal cell carcinomaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF139 | ENST00000303545.4 | c.571G>A | p.Val191Met | missense_variant | Exon 2 of 2 | 1 | NM_007218.4 | ENSP00000304051.4 | ||
RNF139 | ENST00000716592.1 | c.571G>A | p.Val191Met | missense_variant | Exon 2 of 2 | ENSP00000520565.1 | ||||
RNF139 | ENST00000517684.2 | c.190G>A | p.Val64Met | missense_variant | Exon 2 of 2 | 3 | ENSP00000429836.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251100 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461834Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727218 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.571G>A (p.V191M) alteration is located in exon 2 (coding exon 2) of the RNF139 gene. This alteration results from a G to A substitution at nucleotide position 571, causing the valine (V) at amino acid position 191 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at